Determinants of prescribing decisions for off-patent biological medicines in Belgium:a qualitative study
Background A competitive market for off-patent biologicals leads to more affordable and high-quality healthcare. In recent years, Belgium has been characterized by its low use of biosimilars and by its shifts from off-patent biologicals toward new alternative therapies. Yet, the prescribing decisions involved in these observations are poorly understood. This study aims to better understand prescribing choices among Belgian physicians in the ambulatory care setting. Methods This study consisted of two phases. First, a scoping literature review to identify determinants of prescribing choices was... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2022 |
Reihe/Periodikum: | Vandenplas , Y , Simoens , S , Van Wilder , P , Vulto , A G , Turk , F & Huys , I 2022 , ' Determinants of prescribing decisions for off-patent biological medicines in Belgium : a qualitative study ' , Bmc Health Services Research , vol. 22 , no. 1 , 1211 . https://doi.org/10.1186/s12913-022-08591-1 |
Schlagwörter: | /dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being / name=SDG 3 - Good Health and Well-being |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-26995798 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://pure.eur.nl/en/publications/4bba51bd-2717-40c0-ac13-9a69b0623694 |